An experienced biotechnology entrepreneur and the former Chief Executive Officer of Avalanche Biotechnologies, Inc., Thomas Chalberg has earned recognition as a biotechnology thought leader in Silicon Valley. Tom Chalberg co-founded Avalanche Biotechnologies, a gene therapy R&D company for ophthalmic conditions. He joined Avalanche as its first employee, and as CEO grew the company to more than 75 employees.
As a technical expert in the gene therapy field, Thomas Chalberg is an author on a number of peer-reviewed publications in top journals, including The Lancet and Nature Biotechnology, and has served as Principal Investigator for a National Institutes of Health Small Business Innovatio
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
